Inventor · disambiguated record
Rao Kolluri
Also filed as: KOLLURI RAO · KOLLURI RAO S · KOLLURI RAO S S
31 granted patents·10 pending applications·78 citations·filing 2003–2024
96Inventor score
Top patents by PatentIndex Score
41 records- 0197US11407736B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·4 cites·8 claims
- 0296US11629136B1Substituted pyridine derivatives as SARM1 inhibitorsNURA BIO INC·Filed 2022·Granted Apr 18, 2023·4 cites·29 claims
- 0392US12110285B2Substituted pyridine derivatives as SARM1 inhibitorsNURA BIO INC·Filed 2023·Granted Oct 8, 2024·1 cites·19 claims
- 0488US11110082B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Sep 7, 2021·2 cites·28 claims
- 0588US9566278B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·6 cites·21 claims
- 0687US2024368119A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0785US9321763B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Apr 26, 2016·6 cites·64 claims
- 0885US8377924B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Feb 19, 2013·9 cites·31 claims
- 0984US9732070B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Aug 15, 2017·4 cites·27 claims
- 1083US10434096B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Oct 8, 2019·2 cites·6 claims
- 1183US9682976B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Jun 20, 2017·3 cites·55 claims
- 1283US9169249B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Oct 27, 2015·4 cites·17 claims
- 1383US8993585B2Cyclic amine substituted pyrimidinediamines as PKC inhibitorsSINGH RAJINDER·Filed 2008·Granted Mar 31, 2015·7 cites·29 claims
- 1482US2025092057A1Heterocyclic rip1 inhibitory compoundsRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1581US10130623B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Nov 20, 2018·2 cites·39 claims
- 1681US9913843B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Mar 13, 2018·3 cites·5 claims
- 1781US9181222B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Nov 10, 2015·4 cites·18 claims
- 1881US8710223B2Protein kinase C inhibitors and uses thereofHOLLAND SACHA·Filed 2011·Granted Apr 29, 2014·7 cites·2 claims
- 1980US9149475B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2012·Granted Oct 6, 2015·5 cites·21 claims
- 2080US2023112865A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2176US2023143161A1Heterocyclic rip1 inhibitory compoundsRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2275US12297202B2RIP1K inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2023·Granted May 13, 2025·0 cites·4 claims
- 2375US11672791B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Jun 13, 2023·0 cites·20 claims
- 2475US7776847B2Benzisothiazoles useful for treating or preventing HCV infectionRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Aug 17, 2010·3 cites·5 claims
- 2573US7498353B2Heterocyclic anti-viral compounds comprising metabolizable moieties and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Mar 3, 2009·2 cites·24 claims
- 2671US11578078B2Heterocyclic RIP1 inhibitory compoundsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Feb 14, 2023·0 cites·18 claims
- 2767US11667643B2RIP1K inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·0 cites·19 claims
- 2864US10851093B2Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Dec 1, 2020·0 cites·17 claims
- 2963US2023310454A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3062US2021078990A1Tyrosine kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3161US10792282B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Oct 6, 2020·0 cites·17 claims
- 3260US9095593B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 4, 2015·0 cites·8 claims
- 3357US10005777B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Jun 26, 2018·0 cites·14 claims
- 3457US9062068B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Jun 23, 2015·0 cites·25 claims
- 3556US2017360786A1Protein Kinase C Inhibitors and Uses ThereofRIGEL PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3654US11564930B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jan 31, 2023·0 cites·55 claims
- 3754US9453028B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Sep 27, 2016·0 cites·6 claims
- 3845US2011130415A1Protein kinase c inhibitors and uses thereofSINGH RAJINDER·Filed 2010·Application pending·0 cites
- 3945US2005215614A1Substituted indoles and their use as hcv inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 4044US8394951B2Protein kinase C inhibitors and uses thereofZHAO HAORAN·Filed 2010·Granted Mar 12, 2013·0 cites·31 claims
- 4141US2005239751A1Heterocyclic anti-viral compounds comprising metabolizable moieties and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rao Kolluri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →